Biogen shares rally as Alzheimer's drug results show promise

France Nouvelles Nouvelles

Biogen shares rally as Alzheimer's drug results show promise
France Dernières Nouvelles,France Actualités
  • 📰 CBSNews
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

Shares of Biogen and Japanese pharmaceutical company Eisai jumped Wednesday after the drug makers said their potential treatment for Alzheimer's showed promise in slowing the fatal disease that afflicts more than 6 million Americans.

Shares of Biogen and Japanese pharmaceutical company Eisai jumped Wednesday after the drug makers said their potential treatment for Alzheimer's showed promise in slowing the fatal disease that afflicts more than 6 million Americans. results from a late-stage study of nearly 1,800 people with early-stage Alzheimer's. The infused treatment, lecanemab, curtailed patient decline by 27% when compared to a placebo after 18 months.

The company is already seeking an accelerated approval from the U.S. Food and Drug Administration, and the agency is expected to decide by early next year. Eisai and Biogen will co-promote the drug.The initial results appear to be"quite robust" and will likely support regulatory approval, Mizuho Securities analyst Graig Suvannavejh said in a research note.

Beyond the one in three seniors that die with Alzheimer's or another dementia, their toll extends to the more than 11 million Americans who provide unpaid care for those afflicted, according to the Alzheimer's Association. ItBiogen's Aduhelm flops

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CBSNews /  🏆 87. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Alzheimer's drug slowed progression of disease in late-stage study, drugmakers sayAlzheimer's drug slowed progression of disease in late-stage study, drugmakers sayIn a widely-anticipated study, Eisai and Biogen on Tuesday said their Alzheimer's drug slowed cognitive decline among people with early signs of the disease.
Lire la suite »

Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug successRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug successBiogen and partner Eisai late Tuesday reported positive results from a late stage, large trial of their experimental Alzheimer's drug.
Lire la suite »

Mariners' late slide continues with 5-0 loss to RangersMariners' late slide continues with 5-0 loss to RangersRookie Josh Jung carried the Rangers to a win over the Mariners Tuesday night. He hit two homers and drove in all five Texas runs in the shutout victory.
Lire la suite »

Hometown crowd to honor late Foo Fighters drummer Taylor Hawkins at the Kia Forum in InglewoodHometown crowd to honor late Foo Fighters drummer Taylor Hawkins at the Kia Forum in InglewoodA star-studded, hometown crowd will honor the late Foo Fighters drummer Taylor Hawkins at the Kia Forum in Inglewood tonight.
Lire la suite »

BiP’s Michael Allio: 7 Things to Know About His Son, Late WifeBiP’s Michael Allio: 7 Things to Know About His Son, Late WifeMichael Allio’s late wife, Laura, died two years before he competed for Katie Thurston’s heart on ‘The Bachelorette’ — get the details
Lire la suite »

TikTok influencer, 21, shot to death after suspicious late-night callTikTok influencer, 21, shot to death after suspicious late-night callTikToker Karla Pardini, 21, was shot dead near her home after receiving an ominous late-night call.
Lire la suite »



Render Time: 2025-03-12 20:15:54